AsiaPacific Markets Slip as Trumps Iran Warning Reignites Oil Supply Fears Belite Bio BLTE Q4 2025 Results Miss Estimates EPS 070 vs 056 Alaska Air ALK Stock Analysis 305 Loss Key Levels 20260515 Salesforce commits 300 million to Anthropic signaling deepening AI alliance with Slack integration hints Susquehanna Adjusts Power Integrations Price Target Upward Anthropic and Microsoft in Talks for AI Chip Deal Following 5 Billion Investment UK Spy Chief Warns of Moment of Consequence Geopolitical Risks Mount for Investors eHealth EHTH Price Target Raised as Operational Momentum Strengthens Tech and Healthcare Rally Propel SP 500 Higher Financials and Utilities Lag Government Plans Overhaul of CBEC to Ensure Seamless GST Implementation PG Q1 2026 Earnings Slight EPS Miss Weighs on Shares CDXS Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Shares UNIT Q1 2026 Earnings EPS Surprises with a 296 Beat Amid Narrowing Losses Stock Declines CDP Q1 2026 Earnings EPS Beats Estimates by 201 Shares Gain 148 IOVA Q1 2026 Earnings EPS Miss Becomes a Buying Opportunity as Shares Jump Popular Inc Q1 2026 Earnings Strong EPS Beat Drives Modest Share Gains Arcutis Biotherapeutics ARQT Edges Lower as Shares Test Key Support Levels TriNet Group TNET Gains 227 as Stock Approaches Key Resistance Level RLI Corp RLI Edges Lower Testing Support Territory Near 4993 Vroom Inc VRM Slides 518 to 119 Support Level Under Pressure Zentalis Pharmaceuticals ZNTL Rises 152 as Stock Tests Key Resistance Money Market Account Rates Reach Up to 401 APY on May 22 2026 QUQRE Q1 2026 Earnings NarrowerThanExpected Loss Boosts Shares Sleep Number SNBR Sinks to 173 Testing Critical Support Amid Pressure CTAS Q1 2026 Earnings EPS Misses Estimates Stock Sees Modest Gain VERX Q1 2026 Earnings Modest EPS Surprise Marks Steady Performance ANGX Q1 2026 Earnings Earnings Beat Expectations Amid Revenue Uncertainty MSN Q1 2024 Earnings Loss Reported as Stock Surges Over 20 Workiva WK Q1 2026 Earnings EPS Surprises to the Upside Amid Slight Stock Decline GALT Q1 2026 Earnings EPS Misses Estimates as Clinical Development Continues Chemomab Therapeutics Ltd CMMB Q1 2026 Earnings WiderThanExpected Loss Amid PreClinical Progress